| David Leehey, MD | |
|
2160 S First Ave, (luh - North Ent., Rm. 7604), Maywood, IL 60153 | |
| (708) 216-3306 | |
| (708) 216-1259 |
| Full Name | David Leehey |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 48 Years |
| Location | 2160 S First Ave, Maywood, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689651580 | NPI | - | NPPES |
| 36056027 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 36056027 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loyola University Medical Center | Maywood, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Loyola University Medical Center | 3779488903 | 863 |
News Archive
Bristol-Myers Squibb Company and Solvay Pharmaceuticals today announced that the companies have entered into a worldwide agreement for the Solvay compound SLV319, which is currently in Phase I development with potential for use in treating obesity and other metabolic disorders.
Faced with the need to provide daily care, often to family members with special needs or disabilities, caregivers tend to overlook their own short- and long-term personal and financial needs, putting at risk their own health and security.
ARYx Therapeutics, Inc., a biopharmaceutical company, today announced that it has implemented a staffing plan to operate the company that anticipates licensing its lead development programs and resuming development of earlier stage product candidates.
The Icahn School of Medicine at Mount Sinai – an international leader in medical and scientific training, biomedical research, and patient care – today announced the launch of a new Diversity and Inclusion Hub, a groundbreaking initiative spearheaded by the Mount Sinai's Office of Diversity and Inclusion.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.
› Verified 1 days ago
| Entity Name | Loyola University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
Bristol-Myers Squibb Company and Solvay Pharmaceuticals today announced that the companies have entered into a worldwide agreement for the Solvay compound SLV319, which is currently in Phase I development with potential for use in treating obesity and other metabolic disorders.
Faced with the need to provide daily care, often to family members with special needs or disabilities, caregivers tend to overlook their own short- and long-term personal and financial needs, putting at risk their own health and security.
ARYx Therapeutics, Inc., a biopharmaceutical company, today announced that it has implemented a staffing plan to operate the company that anticipates licensing its lead development programs and resuming development of earlier stage product candidates.
The Icahn School of Medicine at Mount Sinai – an international leader in medical and scientific training, biomedical research, and patient care – today announced the launch of a new Diversity and Inclusion Hub, a groundbreaking initiative spearheaded by the Mount Sinai's Office of Diversity and Inclusion.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Leehey, MD 2160 S First Ave, (luh - North Ent., Rm. 7604), Maywood, IL 60153 Ph: (708) 216-3306 | David Leehey, MD 2160 S First Ave, (luh - North Ent., Rm. 7604), Maywood, IL 60153 Ph: (708) 216-3306 |
News Archive
Bristol-Myers Squibb Company and Solvay Pharmaceuticals today announced that the companies have entered into a worldwide agreement for the Solvay compound SLV319, which is currently in Phase I development with potential for use in treating obesity and other metabolic disorders.
Faced with the need to provide daily care, often to family members with special needs or disabilities, caregivers tend to overlook their own short- and long-term personal and financial needs, putting at risk their own health and security.
ARYx Therapeutics, Inc., a biopharmaceutical company, today announced that it has implemented a staffing plan to operate the company that anticipates licensing its lead development programs and resuming development of earlier stage product candidates.
The Icahn School of Medicine at Mount Sinai – an international leader in medical and scientific training, biomedical research, and patient care – today announced the launch of a new Diversity and Inclusion Hub, a groundbreaking initiative spearheaded by the Mount Sinai's Office of Diversity and Inclusion.
BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a privately-held Irish biotech company that has developed proprietary technologies that address key biological analysis protocols – from library preparation of Next Generation Sequencing (NGS) to genotyping for agricultural applications.
› Verified 1 days ago
Dr. Cathryn T Sawalski, DO, MBA Nephrology Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Suhana Elamsenthil, MD Nephrology Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Holly Kramer, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2160 S First Ave, 101-1740 Loyola University Medical Center, Maywood, IL 60153 Phone: 708-216-9000 Fax: 708-216-9033 | |
Dr. Stephanie Bochen Tsai, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-9000 | |
Nicholas Poellinger, MD Nephrology Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Sofia Ahmed, MD Nephrology Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-8757 | |
Shelly Lo, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Luh - North Ent., Rm. 7604, Maywood, IL 60153 Phone: 708-216-3304 Fax: 708-216-1259 |